Peripheral Neuropathy: Advise patients to contact their physicians if they experience new or worsening symptoms of peripheral neuropathy such as tingling, numbness, pain, a burning feeling in the feet or hands, or weakness in the feet or hands [see Warnings and Precautions (5.3)].

Other: Instruct patients to notify their physicians if they experience fever, productive cough, or decreased appetite [see Warnings and Precautions (5.4)].

Manufactured by:
VinCRIStine Sulfate Injection, USP
Hospira Australia Pty Ltd
Mulgrave, Victoria 3170
Australia

Sphingomyelin/Cholesterol Liposome Injection
Cangene Corporation
Winnipeg, Manitoba R3T 5Y3
Canada

Sodium Phosphate Injection
Jubilant HollisterStier
Spokane, WA 99207

Marqibo Kit for the Preparation of vinCRIStine sulfate LIPOSOME injection
Anderson Packaging, Inc
Rockford, IL 61109
Distributed by:
Talon Therapeutics, Inc.
400 Oyster Point Boulevard, Suite 200
South San Francisco, CA 94080
PRINCIPAL DISPLAY PANEL - 5 mg/5 mL Vial Label
NDC 20536-323-01
Rx only
VinCRIStine Sulfate Injection, USP
5 mg/5 mL (1 mg/mL)
for use only in the preparation of Marqibo®
Single Use Vial – Discard Unused Portion
See package insert for preparation instructions
Mfg. for: Talon Therapeutics, Inc., South San Francisco, CA 94080
Mfg. by: Hospira Australia Pty Ltd, Mulgrave VIC 3170, Australia

PRINCIPAL DISPLAY PANEL - 103 mg/mL Vial Label
NDC 20536-324-01
Rx only
Sphingomyelin-Cholesterol Liposome Injection
103 mg/mL
for use only in the preparation of Marqibo®
Single Use Vial – Discard Unused Portion
See package insert for preparation instructions
Mfg. for: Talon Therapeutics, Inc., South San Francisco, CA 94080
Mfg. by: Cangene Corporation, Winnipeg, MB Canada R3T 5Y3

PRINCIPAL DISPLAY PANEL - 355 mg/25 mL Vial Label
NDC 20536-325-01
Rx only
Sodium Phosphate Injection
355 mg/25 mL (14.2 mg/mL)
for use only in the preparation of Marqibo®
Single Use Vial – Discard Unused Portion
See package insert for preparation instructions
Mfg. for: Talon Therapeutics, Inc., South San Francisco, CA 94080
Mfg. by: Jubilant HollisterStier, Spokane, WA 99207
Store at 2°C to 8°C
(36°F to 46°F)
DO NOT FREEZE.

PRINCIPAL DISPLAY PANEL - Kit Label
NDC 20536-322-01
Rx only
Marqibo®
(vinCRIStine sulfate LIPOSOME injection)
Marqibo Kit Contents:
•Sodium Phosphate Injection Vial 355 mg/25 mL (14.2 mg/mL)
•Sphingomyelin-Cholesterol Liposome Injection Vial 103 mg/mL
•VinCRIStine Sulfate Injection, USP Vial 5 mg/5 mL (1 mg/mL)
•Floatation Ring
•Overlabel and Infusion Bag Label
•Package Insert
Store kit at 2°C to 8°C (36°F to 46°F). DO NOT FREEZE.
For Intravenous Use Only
Fatal If Given By Other Routes
Single Use Vials – Discard Unsued Portion

Marqibo
vincristine sulfate kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:20536-322
Packaging
Item Code Package Description
1 NDC:20536-322-01 1 KIT in 1 CARTON
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 VIAL, GLASS 5 mL
Part 2 1 VIAL, GLASS 1 mL
Part 3 1 VIAL, GLASS 25 mL
Part 1 of 3
VINCRISTINE SULFATE
vincristine